JY
Jigyesh Yogesh Patel
About Jigyesh Yogesh Patel
Data last updated:
Jigyesh Yogesh Patel is a Director at Bombay Lifesciences Private Limited (since 2018) and Director at Colossa Lifesciences Private Limited (since 2019). The companies operate in Service and Chemicals. The largest current company by reported revenue is Bombay Lifesciences Private Limited at ₹12.1 Lakh (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Jun 2018 | 2018 | ₹12.1 Lakh (FY 2021) | Active | |
| Director | 08 Jan 2019 | 2019 | Active |
Board colleagues of Jigyesh Yogesh Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nidhi Rajesh Kedar | 08169449 | Bombay Lifesciences Private Limited | Director |
| Pravin Vimalkumar Jain | 07098831 | Bombay Lifesciences Private Limited | Director |
| Gitanjali Prashant Jamkar | 08323702 | Colossa Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jigyesh Yogesh Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jigyesh Yogesh Patel
Jigyesh Yogesh Patel currently holds 2 directorships: Bombay Lifesciences Private Limited (Director, since 29 Jun 2018, revenue ₹12.1 Lakh (FY 2021)); Colossa Lifesciences Private Limited (Director, since 08 Jan 2019).
Jigyesh Yogesh Patel was first appointed on 29 Jun 2018 as Director at Bombay Lifesciences Private Limited. The most recent appointment on record is 08 Jan 2019 at Colossa Lifesciences Private Limited.
The current boards of Jigyesh Yogesh Patel's companies include Nidhi Rajesh Kedar (Bombay Lifesciences Private Limited), Pravin Vimalkumar Jain (Bombay Lifesciences Private Limited), Gitanjali Prashant Jamkar (Colossa Lifesciences Private Limited).